Press Release - Bright Green Corporation

Year

Bright Green Announces Closing of $3.5 Million Private Placement

May 24, 2023

GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for

Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress

May 24, 2023

Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval. Commencement of its fundamental capital raise of $500+ million utilizing the U.S.

Bright Green Announces Pricing of $3.5 Million Private Placement

May 22, 2023

GRANTS, N.M., May 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for

Bright Green Announces the Launch of Its EB-5 Website and Program Following the Historic Announcement of Its Federal Registration and License Approval from the U.S. Drug Enforcement Administration

May 3, 2023

Bright Green, the first publicly traded company in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical and medical applications, can qualify for the EB-5 program and plans to raise $500 million in new capital The

Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis

May 1, 2023

Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical applications and affiliated import and export Company to commence cultivation preparation

Bright Green Announces Fourth Quarter 2022 Financial Update

April 18, 2023

Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board Recently announced capital raise plan of $500+ million utilizing the U.S.

Bright Green Announces Decision to Complete Alterola Biotech Acquisition

April 4, 2023

Bright Green to acquire remaining 75% of Alterola common stock Agreements and completion will be subject to customary conditions and regulatory and stockholder approvals Alterola will support Bright Green’s activities to manufacture and distribute federally compliant, pharmaceutical-grade cannabis

Bright Green Responds to False Claims Made Against the Company

February 21, 2023

Denies any association with John Fikany and Jerry Capussi and categorically refutes the insinuations made on behalf of these individuals Company requesting immediate retraction while reserving the right to seek relief Remains focused on executing its business plan to develop cannabis-based

Bright Green Announces the Receipt of Its First Funds from Its EB-5 Program

February 13, 2023

News reinforces Bright Green’s plans to build additional new facilities in Grants, New Mexico, and confirms final requirements and amendments to certificate of occupancy for existing one million square foot greenhouse Once new facilities are completed, agricultural complex is anticipated to be the

Bright Green Announces Appointment of Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer

February 9, 2023

Terry Rafih to remain as Executive Chairman of the Board Appointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well as its greenhouse expansion plans The Company confirms the receipt of its first funds from its

Pagination

Current page 1
Page 2
Next page
Last page